If you have questions about the work we do or are interested in helping us create a world free of psoriasis, please contact us using the information below.
General information Christy Langan, CEO
Finance and accounting Michele Borsa, Administrative Coordinator
Media Catie Coman, Director of Marketing and Communications
Events and meetings Amanda Bledsoe, Senior Meeting and Events Planner
Partnership opportunities Tina A. Burke, Director of Corporate Relations
Education programs Nicora Gardner, MSW, Senior Education and Outreach Manager
Medical and scientific affairs Peter van de Kerkhof, MD, PhD, Chief Medical Officer
now available COVID-19 Psoriasis Resource Center Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve explore now
Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve
Latest news Commentary: The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologicsMay 28, 2020Searching for signals of increased risk of infection in specific subgroups is vitally important, especially when confronted with a severe threat to health, like the worldwide spread of the SARS-CoV-2 virus. Stories from the Field: COVID-19 and Psoriatic ArthritisMay 27, 2020US-based rheumatologist and IPC Councilor Arthur Kavanaugh, MD, discusses his plans to continue offering telemedicine appointments to patients after the pandemic. "Telemedicine is a new skill set that [we] providers need to learn," says Dr. Kavanaugh in this week's Stories from the Field video. Translations NOW AVAILABLE: January 2020 Psoriasis Review NewsletterMay 26, 2020 Stories from the Field: Impact of COVID-19 restrictions on psoriasis patients in EgyptMay 20, 2020Due to COVID-19 restrictions, patients in Egypt with severe psoriasis are not getting timely access to biologic treatment. IPC Board Member Mahira Hamdy El Sayed, MSc, MD, discusses the potential fallout for Egyptians with psoriasis, post-COVID-19. More News